CharlesWarrenLappMD
Medicine/Pediatrics • Charlotte, NCHunter-Hopkins Center, PLLC Specializing in chronic fatigue, fibromyalgia, PASC and related disorders; medical consultant to AIM Immunotherapy, makers of Ampligen /rintatolimod
Dr. Lapp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7421 Carmel Executive Park Dr
Ste 320
Charlotte, NC 28226Phone+1 704-543-9692Fax+1 704-543-8547
Summary
- Charles Lapp, MD is a healthcare professional based in Charlotte, NC, specializing in Medicine/Pediatrics. He completed his education in Internal Medicine (1974-1976) and Pediatrics (1976-1977) at the University of North Carolina Hospitals after graduating from Albany Medical College in 1974. Dr. Lapp has experience in managing fibromyalgia, chronic fatigue syndrome, orthostatic intolerance, and post-acute sequelae of covid. His contributions include numerous publications in reputable journals like Mayo Clinic Proceedings and American Journal of Epidemiology, with several citations. He has also been involved in clinical trials focusing on the safety and efficacy of Ampligen in treating Chronic Fatigue Syndrome. Dr. Lapp retired from patient care in March 2024, and is currently consulting with Hunter-Hopkins Center as well as AIM Immunotech pharmaceuticals.
Education & Training
University of North Carolina HospitalsResidency, Pediatrics, 1976 - 1977- University of North Carolina HospitalsResidency, Internal Medicine, 1974 - 1976
Albany Medical CollegeClass of 1974
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Clinical Trials
- Ampligen in Chronic Fatigue Syndrome
- The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome Start of enrollment: 1998 Dec 01
Publications & Presentations
PubMed
- 113 citationsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.Lucinda Bateman, Alison C. Bested, Hector Bonilla, Bela V. Chheda, Lily Chu
Mayo Clinic Proceedings. 2021-11-01 - 71 citationsEstimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning.Ashley R. Valdez, Elizabeth E. Hancock, Seyi Adebayo, David J. Kiernicki, Daniel Proskauer
Frontiers in Pediatrics. 2019-01-08 - 27 citationsMulti-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort St...Elizabeth R. Unger, Jin-Mann S. Lin, Hao Tian, Benjamin H. Natelson, Gudrun Lange
American Journal of Epidemiology. 2017-04-15
Journal Articles
- Managing Covid-19 Post Viral Fatigue SyndromeLapp C and J John, Fatigue: Biomedicine, Health & Behavior, 2/10/2021
Press Mentions
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for Its ME/CFS and Long COVID ProgramsApril 15th, 2024- Treatments Explored to Ease Postviral Symptoms of ME/CFS and Long COVIDAugust 8th, 2022
- AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Intranasal and an IV Therapy for Post-COVID-19 Cognitive Dysfunction (PCCD)August 25th, 2021
- Join now to see all
Industry Relationships
- Consultant / Thought Leader / Speaker, Pfizer2010 - 2015
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
